生物
选择性拼接
基因亚型
内含子
外显子
成纤维细胞生长因子
细胞生物学
亚科
RNA剪接
基因
成纤维细胞生长因子受体
遗传学
受体
核糖核酸
作者
Martyna Biaduń,Radosław Karelus,Daniel Krowarsch,Łukasz Opaliński,Małgorzata Zakrzewska
出处
期刊:Differentiation
[Elsevier BV]
日期:2023-11-01
卷期号:: 100740-100740
被引量:3
标识
DOI:10.1016/j.diff.2023.100740
摘要
Fibroblast growth factor 12 (FGF12) belongs to the fibroblast growth factor homologous factors (FHF) subfamily, which is also known as the FGF11 subfamily. The human FGF12 gene is located on chromosome 3 and consists of four introns and five coding exons. Their alternative splicing results in two FGF12 isoforms - the shorter 'b' isoform and the longer 'a' isoform. Structurally, the core domain of FGF12, is highly homologous to that of the other FGF proteins, providing the classical tertiary structure of β-trefoil. FGF12 is expressed in various tissues, most abundantly in excitable cells such as neurons and cardiomyocytes. For many years, FGF12 was thought to be exclusively an intracellular protein, but recent studies have shown that it can be secreted despite the absence of a canonical signal for secretion. The best-studied function of FGF12 relates to its interaction with sodium channels. In addition, FGF12 forms complexes with signaling proteins, regulates the cytoskeletal system, binds to the FGF receptors activating signaling cascades to prevent apoptosis and interacts with the ribosome biogenesis complex. Importantly, FGF12 has been linked to nervous system disorders, cancers and cardiac diseases such as epileptic encephalopathy, pulmonary hypertension and cardiac arrhythmias, making it a potential target for gene therapy as well as a therapeutic agent.
科研通智能强力驱动
Strongly Powered by AbleSci AI